These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 22127697

  • 1. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ, Sørensen IJ, Lambert RG, Hermann KG, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M.
    Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
    [Abstract] [Full Text] [Related]

  • 2. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I.
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors.
    Pedersen SJ, Hetland ML, Sørensen IJ, Ostergaard M, Nielsen HJ, Johansen JS.
    Clin Rheumatol; 2010 Nov; 29(11):1301-9. PubMed ID: 20640910
    [Abstract] [Full Text] [Related]

  • 5. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
    Syversen SW, Goll GL, van der Heijde D, Landewé R, Gaarder PI, Odegård S, Haavardsholm EA, Kvien TK.
    J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
    [Abstract] [Full Text] [Related]

  • 6. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
    Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY.
    Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
    Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J.
    Arthritis Res Ther; 2008 Aug; 10(5):R125. PubMed ID: 18945353
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
    Niki Y, Takeuchi T, Nakayama M, Nagasawa H, Kurasawa T, Yamada H, Toyama Y, Miyamoto T.
    PLoS One; 2012 Aug; 7(5):e37447. PubMed ID: 22629396
    [Abstract] [Full Text] [Related]

  • 9. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
    Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D.
    Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713
    [Abstract] [Full Text] [Related]

  • 10. Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
    Braun J, Baraliakos X, Hermann KG, Xu S, Hsu B.
    J Rheumatol; 2016 Sep; 43(9):1704-12. PubMed ID: 27422890
    [Abstract] [Full Text] [Related]

  • 11. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 12. Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis.
    Almodóvar R, Ríos V, Ocaña S, Gobbo M, Casas ML, Zarco-Montejo P, Juanola X.
    Clin Rheumatol; 2014 Feb; 33(2):237-41. PubMed ID: 23917391
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort.
    Blachier M, Canouï-Poitrine F, Dougados M, Lethuaut A, Fautrel B, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Bastuji-Garin S, Claudepierre P.
    Rheumatology (Oxford); 2013 Sep; 52(9):1686-93. PubMed ID: 23764945
    [Abstract] [Full Text] [Related]

  • 14. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
    Roux-Lombard P, Eberhardt K, Saxne T, Dayer JM, Wollheim FA.
    Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
    [Abstract] [Full Text] [Related]

  • 15. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
    Garnero P, Thompson E, Woodworth T, Smolen JS.
    Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
    [Abstract] [Full Text] [Related]

  • 16. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation.
    Pedersen SJ, Chiowchanwisawakit P, Lambert RG, Østergaard M, Maksymowych WP.
    J Rheumatol; 2011 Jul; 38(7):1349-54. PubMed ID: 21459937
    [Abstract] [Full Text] [Related]

  • 17. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA, Schett G, Emery P, Harari O, Byrjalsen I, Kenwright A, Bay-Jensen AC, Platt A.
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [Abstract] [Full Text] [Related]

  • 18. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis.
    Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD.
    J Rheumatol; 2013 Jun; 40(6):866-71. PubMed ID: 23637322
    [Abstract] [Full Text] [Related]

  • 19. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U, Poulsen UE, Espesen J, Schlemmer A, Graudal N, Kollerup G, Jensen DV, Madsen OR, Glintborg B, Christensen T, Lindegaard H, Bøhme W, Hansen A, Andersen AR, Hetland ML.
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [Abstract] [Full Text] [Related]

  • 20. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
    Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M.
    Arthritis Rheum; 2012 May; 64(5):1388-98. PubMed ID: 22127957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.